
A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer
Author(s) -
Rebecca S. Heist,
Xiaofei Wang,
Lydia Hodgson,
Gregory A. Otterson,
Thomas E. Stinchcombe,
Leena Gandhi,
Miguel A. VillalonaCalero,
Peter Watson,
Everett E. Vokes,
Mark A. Socinski
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/3dv7-hd87
Subject(s) - pemetrexed , sunitinib , medicine , oncology , lung cancer , phases of clinical research , second line treatment , cancer , clinical trial , chemotherapy , cisplatin